×
How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? PDF
$ 40.00
How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? PDF quantity
$ 40.00
×
Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients PDF
$ 40.00
Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients PDF quantity
$ 40.00
×
A Comparison of Selected Risk Factors for Unipolar Depressive Disorder, Bipolar Affective Disorder, Schizoaffective Disorder, and Schizophrenia From a Danish Population-Based Cohort PDF
$ 40.00
A Comparison of Selected Risk Factors for Unipolar Depressive Disorder, Bipolar Affective Disorder, Schizoaffective Disorder, and Schizophrenia From a Danish Population-Based Cohort PDF quantity
$ 40.00
×
Gender-Specific Suicide Risk Factors: A Case-Control Study of Individuals With Major Depressive Disorder PDF
$ 40.00
Gender-Specific Suicide Risk Factors: A Case-Control Study of Individuals With Major Depressive Disorder PDF quantity
$ 40.00
×
Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials. PDF
$ 40.00
Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials. PDF quantity
$ 40.00
×
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial PDF
$ 40.00
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
